| abstract |
The present invention relates to a compound of formula I, or a pharmaceutically acceptable salt or solvate thereof, comprising any possible stereoisomer, (I) Wherein R < 9 > has the meanings as defined herein. The present invention also relates to methods of making such compounds, pharmaceutical compositions containing them and their use in HCV therapy, alone or in combination with other HCV inhibitors. |